Coherent: Post-Correction Alpha Blueprint (Rating Upgrade)

Coherent is presented as an AI-infrastructure beneficiary trading at 28.8x forward P/E and a 0.55 PEG, with a projected valuation re-rating toward $454.43. Catalysts include Thermadite/SiC cooling, the PhotonLink platform launch, and management incentive targets, while a transition to 6-inch InP wafers and expanded U.S./European production are expected to support gross margins above 45% by mid-2027.

Analysis

The investable question is whether COHR can convert AI-optics demand into mix-driven gross-margin expansion faster than price competition emerges in transceivers and optical components. The likely near-term beneficiary of any credible design-win evidence is COHR’s multiple, but LITE and AAOI provide cleaner read-through comparables: if industry demand is broad, their orders and utilization should improve alongside COHR; if only COHR rerates, the move is more likely narrative-driven. The proposed valuation case relies on execution across new products, wafer yields, and capacity ramps—three areas where delays typically create inventory absorption and margin volatility rather than linear upside.

Over the next 1-3 months, the relevant catalyst is not an aspirational platform launch but confirmation in bookings, hyperscaler qualification, and backlog conversion. A gross-margin guide increase accompanied by stable working capital would be materially more credible than compensation-linked targets, which should not be treated as independent evidence of earnings power. Conversely, elevated receivables, inventory growth ahead of revenue, or a weak optical-components outlook from peers would signal that capacity is being added into a cyclical demand pocket rather than a durable share-gain cycle.

The contrarian view is that a low PEG can be a lagging artifact when the earnings estimate base embeds a recovery that has not yet been de-risked. COHR has meaningful operating leverage, so a modest miss on utilization or yield can drive outsized EPS downside and prevent multiple expansion; this is especially relevant if AI spending rotates toward compute/networking vendors with clearer revenue recognition. Over 6-18 months, domestic production optionality could support strategic customer wins, but it also raises fixed-cost exposure unless utilization ramps on schedule.

Key Decisions for Investors

• Watch, do not chase COHR on launch headlines. Upgrade to a 1-3 month long only if the next report shows bookings/backlog conversion and gross-margin guidance moving higher without disproportionate inventory or receivables growth; use a post-earnings entry with a stop on a guidance reversal.
• For AI-optics exposure, consider a 3-6 month relative-value pair: long COHR / short LITE only if COHR demonstrates superior margin progression or named qualification evidence. The thesis is company-specific execution; a sector-wide optics slowdown is the key risk and would invalidate the pair.
• Maintain a downside alert around the next earnings cycle: any reduction in the path to mid-40% gross margin, evidence of wafer-yield slippage, or below-peer order commentary should be treated as a catalyst for multiple compression rather than a buy-the-dip opportunity.
• Use AAOI and LITE results as leading demand checks before establishing size in COHR. Broad improvements in optical-component utilization support the cycle; divergent weakness would suggest COHR’s re-rating case depends on unverified share gains.